ORKA
Income statement / Annual
Last year (2024), Oruka Therapeutics Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2024, Oruka Therapeutics Inc.'s net income was -$83.72 M.
See Oruka Therapeutics Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$27,000.00
|
$111,000.00
|
$114,000.00
|
$91,000.00
|
$93,000.00
|
| Gross Profit |
-$27,000.00
|
-$111,000.00
|
-$114,000.00
|
-$91,000.00
|
-$93,000.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$75.06 M
|
$1.01 M
|
$4.46 M
|
$13.83 M
|
$4.99 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$13.04 M
|
$6.17 M
|
$5.26 M
|
$5.41 M
|
$4.68 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
$88.10 M
|
$7.19 M
|
$9.73 M
|
$19.24 M
|
$9.67 M
|
| Cost And Expenses |
$88.12 M
|
$7.30 M
|
$9.84 M
|
$19.34 M
|
$9.77 M
|
| Interest Income |
$5.86 M
|
$1.96 M
|
$675,000.00
|
$0.00
|
$0.00
|
| Interest Expense |
$1.47 M
|
$0.00
|
$0.00
|
$0.00
|
$9,000.00
|
| Depreciation & Amortization |
$27,000.00
|
$111,000.00
|
$114,000.00
|
$91,000.00
|
$93,000.00
|
| EBITDA |
-$82.23 M |
-$5.23 M |
-$9.81 M |
-$19.23 M |
-$9.65 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
$4.40 M
|
$1.96 M
|
-$85,000.00
|
$13,000.00
|
$19,000.00
|
| Income Before Tax |
-$83.72 M
|
-$5.34 M
|
-$9.93 M
|
-$19.32 M
|
-$9.75 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
-$9,000.00
|
| Net Income |
-$83.72 M
|
-$5.34 M
|
-$9.93 M
|
-$19.32 M
|
-$9.74 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
| EPS |
-4.99 |
-4.44 |
-8.27 |
-16.68 |
-24.81 |
| EPS Diluted |
-4.99 |
-4.44 |
-8.27 |
-16.68 |
-24.81 |
| Weighted Average Shares Out |
$16.79 M
|
$1.20 M
|
$1.20 M
|
$1.16 M
|
$392,519.00
|
| Weighted Average Shares Out Diluted |
$16.79 M
|
$1.20 M
|
$1.20 M
|
$1.16 M
|
$392,519.00
|
| Link |
|
|
|
|
|
